MLLr leukemia is initiated by a translocation of the MLL gene to over 100 known fusion partners in hematopoietic stem and progenitor cells (HSPCs), thereby generating a highly oncogenic fusion protein that drives the disease with fewer secondary mutations than other leukemias [7,71]. Here, KMT2A is linked to leukemia.